Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Effects of acute doxorubicin treatment on hepatic proteome lysine acetylation status and the apoptotic environment. World J Biol Chem 2014 Aug 26;5(3):377-86 PMID: 25225604 PMCID: PMC4160530

Abstract

AIM: To determine if doxorubicin (Dox) alters hepatic proteome acetylation status and if acetylation status was associated with an apoptotic environment.

METHODS: Doxorubicin (20 mg/kg; Sigma, Saint Louis, MO; n = 8) or NaCl (0.9%; n = 7) was administered as an intraperitoneal injection to male F344 rats, 6-wk of age. Once animals were treated with Dox or saline, all animals were fasted until sacrifice 24 h later.

RESULTS: Dox treatment decreased proteome lysine acetylation likely due to a decrease in histone acetyltransferase activity. Proteome deacetylation may likely not be associated with a proapoptotic environment. Dox did not increase caspase-9, -8, or -3 activation nor poly (adenosine diphosphate-ribose) polymerase-1 cleavage. Dox did stimulate caspase-12 activation, however, it likely did not play a role in apoptosis induction.

CONCLUSION: Early effects of Dox involve hepatic proteome lysine deacetylation and caspase-12 activation under these experimental conditions.

Author List

Dirks-Naylor AJ, Kouzi SA, Bero JD, Tran NT, Yang S, Mabolo R

Author

Sendra Yang PharmD Clinical Assistant Professor in the School of Pharmacy department at Medical College of Wisconsin



View this publication's entry at the Pubmed website PMID: 25225604
jenkins-FCD Prod-153 3ca6710ea990189ceb85f4312e7298b5922ce1a6